Expression of Fas antigen in liver tissue of patients with chronic hepatitis B and C

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 3, 2004, Pages 341-345

  Oksuz, Murat ^a,b   Akkiz, Hikmet ^a   Isiksal, Y Fatih ^a   Saydaoglu, Gülsah ^a   Serin, Mehmet ^a   Kayaselcuk, Fazilet ^a   Abayli, Bahri ^a   Tuncer, Ilhan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b Kurtulus Mah Ziyapasa Bulvari   (Turkey)

Author keywords

Apoptosis; Chronic viral hepatitis B; Chronic viral hepatitis C; Fas antigen

Indexed keywords

FAS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SAMPLE; SCORING SYSTEM; TISSUE DISTRIBUTION;

EID: 1642313786     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200403000-00015     Document Type: Article

References (31)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
2. Gerard F. Liver apoptosis. J Hepatol 1997; 26 (suppl):1-11.
3. Russel JH. Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995; 7:382-391.
4. Bettinardi A, Brugnoni D, Quiros-Roldan E, Malagoli A, La Grutta S, Correra A, et al. Missense mutation in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 1997; 89:902-909.
5. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, et al. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 1994; 152:3245-3253.
6. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68:251-306.
7. Chu CM, Shyu WC, Kuo RW, Liaw YF. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis. Hepatology 1987; 7:1311-1316.
8. Fukusato T, Gerber MA, Thung SN, Ferrone S. Expression of HLA class I antigens of hepatocytes in liver disease. Am J Pathol 1986; 123:264-270.
9. Ruggieri A, Harada T, Matsuura Y, Miyamura T. Sensitization to Fas mediated apoptosis by hepatitis C virus core protein. Virology 1996; 229:68-76.
10. Nagata S. Fas and Fas Ligand: a death factor and its receptor. Adv Immunol 1996; 57:129-144.
11. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267:1449-1456.
12. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994; 179:873-879.
13. Takahashi T, Tanaka M, Inazawa T, Abe T, Suda T, Nagata S. Human FasLigand: gene structure, chromosomal location and species specificity. Int Immunol 1994; 6:1567-1574.
14. Kienar PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, et al. Differential induction of apoptosis by Fas-FasLigand interactions in human monocytes and macrophages. J Exp Med 1997; 185:1511-1516.
15. 2+ dependent T cell-mediated cytotoxicity. J Exp Med 1993; 177:195-200.
16. Lowin B, Hahne M, Mattmann C. Cytolytic T-cell cytotoxicity is mediated through perforin and FasLytic pathways. Nature 1994; 370:650-652.
17. Suda T. Expression of the Fas Ligand in T-cell-linage. J Immunol 1995; 154:3806-3813.
18. Kagi D. Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265:528-530.
19. Kojima H, Shinohara S, Hanaoka Y, Someya-Shirota Y, Takagi Y, Ohono H, et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994; 1:357-364.
20. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the FasLigand in the development of hepatitis. Nature 1997; 4:409-413.
21. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 1992; 149:3166-3175.
22. Ogasawara J, Fukunaga RW, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364:806-809.
23. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, et al. Immunohistochemical detection of Fas antigen in liver tissues of patients with chronic hepatitis C. Hepatology 1994; 19:1354-1359.
24. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996; 24:1-7.
25. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S, et al. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 1990; 87:9620-9624.
26. Bartley AD, Dockrel D, Simpson M, Schut R, Lynch DH, Leibson P, et al. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 1997; 1:55-64.
27. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 5:431-435.
28. Takehara T, Hayashi N, Katayama K, Kasahara A, Fusamoto H, Kato M, et al. Two-dimensional flow cytometric analysis of intrahepatic lymphocyte subsets from patients with chronic hepatitis. Dig Dis Sci 1991; 36:87-91.
29. Russel JH. Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol Rev 1983; 72:97-118.
30. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263:1759-1762.
31. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32:223-254.